Entera Bio (ENTX) Assets Average (2018 - 2026)
Entera Bio's (ENTX) quarterly Assets Average came in at $14.6 million in Q1 2026, down 6.03% YoY from $15.5 million in Q1 2025, and down 12.81% on a QoQ basis from $16.7 million in Q4 2025.
Entera Bio (ENTX) Assets Average (2018 - 2026) Analysis & Trends
Entera Bio (ENTX) has 7 years of Assets Average data on file, last reported at $14.6 million in Q1 2026.
- Quarterly Assets Average fell 6.03% year-over-year to $14.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.6 million (down 6.03% YoY) and the FY2025 annual result came in at $12.7 million, up 19.99% from the prior year.
- Assets Average eased to $14.6 million in Q1 2026, from $16.7 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $24.1 million in Q1 2022 to a low of $8.6 million in Q4 2024.
- A 5-year average of $14.4 million and a median of $14.3 million in 2022 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2023 — Assets Average tumbled 48.79% — and 2025, when it soared 108.56%.
- Tracing ENTX's Assets Average over 5 years: stood at $14.3 million in 2022, then fell by 29.08% to $10.2 million in 2023, then fell by 15.74% to $8.6 million in 2024, then soared by 94.97% to $16.7 million in 2025, then fell by 12.81% to $14.6 million in 2026.
- The last three Assets Average figures came in at $14.6 million (Q1 2026), $16.7 million (Q4 2025), and $18.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.24 Bn | 131.39 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 86.01 Bn | 78.02 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 65.61 Bn | 60.42 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.92 Bn | 51.78 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 27.77 Bn | 9.38 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 19.82 Bn |
| 10 | Entera Bio | 166.42 Mn | 155.11 Mn | - | 16.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.30 Mn |
| Mar 31, 2026 | 14.56 Mn |
| Dec 31, 2025 | 16.70 Mn |
| Sep 30, 2025 | 18.54 Mn |
| Jun 30, 2025 | 20.63 Mn |
| Mar 31, 2025 | 15.50 Mn |
| Dec 31, 2024 | 8.57 Mn |
| Sep 30, 2024 | 8.89 Mn |
| Jun 30, 2024 | 10.14 Mn |
| Mar 31, 2024 | 11.00 Mn |
| Dec 31, 2023 | 10.17 Mn |
| Sep 30, 2023 | 9.51 Mn |
| Jun 30, 2023 | 11.03 Mn |
| Mar 31, 2023 | 12.37 Mn |
| Dec 31, 2022 | 14.33 Mn |
| Sep 30, 2022 | 17.31 Mn |
| Jun 30, 2022 | 20.70 Mn |
| Mar 31, 2022 | 24.15 Mn |
| Dec 31, 2020 | 10.59 Mn |
| Jun 30, 2020 | 14.08 Mn |